Institute of Biomedical Research Corp. (MRES)
OTCMKTS · Delayed Price · Currency is USD
0.0020
-0.0005 (-20.00%)
Feb 12, 2026, 11:07 AM EST
MRES Market Cap
MRES has a market cap or net worth of $6.87 million as of February 12, 2026. Its market cap has decreased by -71.06% in one year.
Market Cap
6.87M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 31, 2016, MRES's market cap has increased from 693.95K to 6.87M, an increase of 890.46%. That is a compound annual growth rate of 26.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 5.50M | -28.57% |
| Dec 31, 2025 | 7.70M | -83.96% |
| Dec 31, 2024 | 47.98M | 138.03% |
| Dec 29, 2023 | 20.16M | 17.54% |
| Dec 30, 2022 | 17.15M | 149.69% |
| Dec 31, 2021 | 6.87M | 971.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curative Biotechnology | 7.94M |
| NKGen Biotech | 7.84M |
| Synlogic | 7.78M |
| BetterLife Pharma | 6.49M |
| Brainstorm Cell Therapeutics | 6.46M |
| GPL Holdings | 5.83M |
| Bioxytran | 5.56M |
| LakeShore Biopharma | 5.33M |